Determining the Optimal Dose of Reactive Balance Training After Stroke

Stroke Clinical Trial

Official title: Determining the Optimal Dose of Reactive Balance Training After Stroke - a Pilot Study

Status Recruiting

Clinical Trial Summary

Falls in daily life are one of the most significant complications for people with stroke. Fall rates are particularly high soon after discharge from stroke rehabilitation. A new type of balance training, called reactive balance training (RBT), can reduce fall rates after discharge from stroke rehabilitation. In our previous study, RBT was implemented as part of routine care, and as a result, the dose of training was different for each participant; participants completed between one and twelve 30-minute sessions of RBT. Previous research in healthy older adults suggests that a single session of RBT is enough to lead to lasting changes in reactive balance control and reduce fall rates in daily life. It is not clear if the same is true for people with stroke, who have more severe impairments and might need a higher dose of training to achieve the same benefits.

The overall goal of this work is to determine the optimal dose of reactive balance training for people with stroke who are attending rehabilitation. This pilot study will determine the feasibility of a clinical trial to address this larger goal. People with sub-acute stroke will be randomly assigned to one of three groups: 1 session, 3 sessions, or 6 sessions of RBT. Each session will be 45 minutes long, and will occur as part of participants' routine out-patient rehabilitation. We will use our experiences with this pilot study to help design a larger study. Specifically, we will use this pilot study to answer the following questions: 1) what is the optimal sample size; 2) how long will it take to reach this sample size; 3) what outcome measures should be used; 4) how feasible is it to prescribe a specific dose of RBT to people with sub-acute stroke; and 5) what two intervention groups should be included in the larger trial?

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Stroke

• NCT number: NCT04219696
• Study type: Interventional
• Source: Toronto Rehabilitation Institute
• Contact: Avril Mansfield, PhD
• Phone: 416-597-3422
• Email: avril.mansfield@uhn.ca
• Status: Recruiting
• Phase: N/A
• Start date: August 20, 2020
• Completion date: July 2024